Use of Medicoeconomic Assessment in Drug Pricing “Unrealistic”: DG for Policy Planning and Evaluation Katori

March 28, 2012
Speaking at a scientific meeting held by the Japan chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) on March 25, Teruyuki Katori, director-general for policy planning and evaluation (in charge of social security), Ministry of Health, Labor...read more